1. Home
  2. PRA vs BHVN Comparison

PRA vs BHVN Comparison

Compare PRA & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProAssurance Corporation

PRA

ProAssurance Corporation

N/A

Current Price

$24.51

Market Cap

1.2B

Sector

Finance

ML Signal

N/A

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

N/A

Current Price

$9.95

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRA
BHVN
Founded
1976
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.6B
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
PRA
BHVN
Price
$24.51
$9.95
Analyst Decision
Hold
Buy
Analyst Count
2
14
Target Price
$25.00
$28.85
AVG Volume (30 Days)
572.3K
1.9M
Earning Date
05-25-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.08
EPS
0.99
N/A
Revenue
$1,098,028,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.30
$7.48
52 Week High
$24.77
$31.18

Technical Indicators

Market Signals
Indicator
PRA
BHVN
Relative Strength Index (RSI) 51.25 38.12
Support Level $23.88 $9.32
Resistance Level $24.64 $10.28
Average True Range (ATR) 0.12 0.71
MACD -0.02 -0.11
Stochastic Oscillator 28.00 16.67

Price Performance

Historical Comparison
PRA
BHVN

About PRA ProAssurance Corporation

ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: